In the phase 3 RASolute 302 trial, daraxonrasib improved overall survival and progression-free survival vs chemotherapy in patients with second-line metastatic pancreatic adenocarcinoma.
In a propensity-matched analysis of stage I-III solid tumors, GLP-1 receptor agonist exposure after cancer diagnosis was associated with lower metastatic progression in several cancer types. These findings...
The FDA has authorized a first-of-its-kind therapeutic device that delivers tumor-treating fields for adults with locally advanced pancreatic cancer. The approval offers a new non-invasive option to extend...
A randomized controlled trial found that both transdiscal and paraspinal splanchnic nerve block approaches effectively reduced pain in advanced pancreatic cancer, with the transdiscal technique offering...
The FDA approved irinotecan liposome with oxaliplatin, fluorouracil, and leucovorin as a first-line regimen for the management of patients with metastatic pancreatic adenocarcinoma.
Endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography are useful tools for the diagnosis and management of chronic pancreatitis in adults. The authors of the new NASPGHAN position...
